메뉴 건너뛰기





Volumn 10, Issue 3, 2004, Pages 270-280

The 9th International Conference on Alzheimer's Disease and Related Disorders. Philadelphia, PA. July 17-22, 2004

Author keywords

Acetylcholinesterase inhibitors; Alzheimer's disease; Cognition; Cognition enhancing drugs; Dementia; New CNS drugs; Amyloid

Indexed keywords

2,3 DIHYDRO 3,4 CYCLOPENTANO 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; ALPHA SECRETASE INHIBITOR; ARIPIPRAZOLE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CLIOQUINOL; CURCUMIN; DIHYDROPYRIDINE DERIVATIVE; DIZOCILPINE; DONEPEZIL; EVODIAMINE; GALANTAMINE; HUPERZINE A; LECOZOTAN; LY 450319; MEM 1003; MEMANTINE; NCX 2057; NEUROLEPTIC AGENT; NEW DRUG; OLANZAPINE; PN 401; QUETIAPINE; RALOXIFENE; RISPERIDONE; RIVASTIGMINE; SEROTONIN 1A ANTAGONIST; TACRINE; TAK 070; UNCLASSIFIED DRUG; UNINDEXED DRUG; AMINO ACID RECEPTOR BLOCKING AGENT; NEUROPROTECTIVE AGENT;

EID: 6344254690     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.2004.tb00027.x     Document Type: Conference Paper
Times cited : (1)

References (0)
  • Reference 정보가 존재하지 않습니다.

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.